Europe Biosimilars Market Report 2017

March 2017 | 100 pages | ID: E8EFEC27674EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Biosimilars

Revenue, means the sales value of Biosimilars

This report studies sales (consumption) of Biosimilars in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Sandoz International
• Hospira
• Teva Pharmaceutical
• Dr. Reddy’s Laboratories
• Biocon
• Mylan
• Amgen
• Celltrion
• Roche Diagnostics
• Merck KGaA

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Biosimilars in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II

Split by application, this report focuses on sales, market share and growth rate of Biosimilars in each application, can be divided into

• Application 1
• Application 2

Contents

Europe Biosimilars Market Report 2017

1 BIOSIMILARS OVERVIEW

1.1 Product Overview and Scope of Biosimilars
1.2 Classification of Biosimilars
  1.2.1 Type I
  1.2.2 Type II
1.3 Application of Biosimilars
  1.3.1 Application
  1.3.2 Application
1.4 Biosimilars Market by Countries
  1.4.1 Germany Status and Prospect (2012-2022)
  1.4.2 France Status and Prospect (2012-2022)
  1.4.3 UK Status and Prospect (2012-2022)
  1.4.4 Russia Status and Prospect (2012-2022)
  1.4.5 Italy Status and Prospect (2012-2022)
  1.4.6 Spain Status and Prospect (2012-2022)
  1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Biosimilars (2012-2022)
  1.5.1 Europe Biosimilars Sales and Growth Rate (2012-2022)
  1.5.2 Europe Biosimilars Revenue and Growth Rate (2012-2022)

2 EUROPE BIOSIMILARS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Biosimilars Market Competition by Manufacturers
  2.1.1 Europe Biosimilars Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Biosimilars Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Biosimilars (Volume and Value) by Type
  2.2.1 Europe Biosimilars Sales and Market Share by Type (2012-2017)
  2.2.2 Europe Biosimilars Revenue and Market Share by Type (2012-2017)
2.3 Europe Biosimilars (Volume and Value) by Countries
  2.3.1 Europe Biosimilars Sales and Market Share by Countries (2012-2017)
  2.3.2 Europe Biosimilars Revenue and Market Share by Countries (2012-2017)
2.4 Europe Biosimilars (Volume) by Application

3 GERMANY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Biosimilars Sales and Value (2012-2017)
  3.1.1 Germany Biosimilars Sales and Growth Rate (2012-2017)
  3.1.2 Germany Biosimilars Revenue and Growth Rate (2012-2017)
  3.1.3 Germany Biosimilars Sales Price Trend (2012-2017)
3.2 Germany Biosimilars Sales and Market Share by Manufacturers
3.3 Germany Biosimilars Sales and Market Share by Type
3.4 Germany Biosimilars Sales and Market Share by Application

4 FRANCE BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

4.1 France Biosimilars Sales and Value (2012-2017)
  4.1.1 France Biosimilars Sales and Growth Rate (2012-2017)
  4.1.2 France Biosimilars Revenue and Growth Rate (2012-2017)
  4.1.4 France Biosimilars Sales Price Trend (2012-2017)
4.2 France Biosimilars Sales and Market Share by Manufacturers
4.3 France Biosimilars Sales and Market Share by Type
4.4 France Biosimilars Sales and Market Share by Application

5 UK BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

5.1 UK Biosimilars Sales and Value (2012-2017)
  5.1.1 UK Biosimilars Sales and Growth Rate (2012-2017)
  5.1.2 UK Biosimilars Revenue and Growth Rate (2012-2017)
  5.1.5 UK Biosimilars Sales Price Trend (2012-2017)
5.2 UK Biosimilars Sales and Market Share by Manufacturers
5.3 UK Biosimilars Sales and Market Share by Type
5.4 UK Biosimilars Sales and Market Share by Application

6 RUSSIA BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Biosimilars Sales and Value (2012-2017)
  6.1.1 Russia Biosimilars Sales and Growth Rate (2012-2017)
  6.1.2 Russia Biosimilars Revenue and Growth Rate (2012-2017)
  6.1.6 Russia Biosimilars Sales Price Trend (2012-2017)
6.2 Russia Biosimilars Sales and Market Share by Manufacturers
6.3 Russia Biosimilars Sales and Market Share by Type
6.4 Russia Biosimilars Sales and Market Share by Application

7 ITALY BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Biosimilars Sales and Value (2012-2017)
  7.1.1 Italy Biosimilars Sales and Growth Rate (2012-2017)
  7.1.2 Italy Biosimilars Revenue and Growth Rate (2012-2017)
  7.1.7 Italy Biosimilars Sales Price Trend (2012-2017)
7.2 Italy Biosimilars Sales and Market Share by Manufacturers
7.3 Italy Biosimilars Sales and Market Share by Type
7.4 Italy Biosimilars Sales and Market Share by Application

8 SPAIN BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Biosimilars Sales and Value (2012-2017)
  8.1.1 Spain Biosimilars Sales and Growth Rate (2012-2017)
  8.1.2 Spain Biosimilars Revenue and Growth Rate (2012-2017)
  8.1.8 Spain Biosimilars Sales Price Trend (2012-2017)
8.2 Spain Biosimilars Sales and Market Share by Manufacturers
8.3 Spain Biosimilars Sales and Market Share by Type
8.4 Spain Biosimilars Sales and Market Share by Application

9 BENELUX BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Biosimilars Sales and Value (2012-2017)
  9.1.1 Benelux Biosimilars Sales and Growth Rate (2012-2017)
  9.1.2 Benelux Biosimilars Revenue and Growth Rate (2012-2017)
  9.1.9 Benelux Biosimilars Sales Price Trend (2012-2017)
9.2 Benelux Biosimilars Sales and Market Share by Manufacturers
9.3 Benelux Biosimilars Sales and Market Share by Type
9.4 Benelux Biosimilars Sales and Market Share by Application

10 EUROPE BIOSIMILARS MANUFACTURERS ANALYSIS

10.1 Sandoz International
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Biosimilars Product Type, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Sandoz International Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Hospira
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Biosimilars Product Type, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Hospira Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Teva Pharmaceutical
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Biosimilars Product Type, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Teva Pharmaceutical Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Dr. Reddy’s Laboratories
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Biosimilars Product Type, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Dr. Reddy’s Laboratories Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Biocon
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Biosimilars Product Type, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Biocon Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Mylan
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Biosimilars Product Type, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Mylan Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Amgen
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Biosimilars Product Type, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Amgen Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Celltrion
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Biosimilars Product Type, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Celltrion Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Roche Diagnostics
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Biosimilars Product Type, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Roche Diagnostics Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Merck KGaA
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Biosimilars Product Type, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Merck KGaA Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview

11 BIOSIMILARS MANUFACTURING COST ANALYSIS

11.1 Biosimilars Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Biosimilars

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Biosimilars Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Biosimilars Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE BIOSIMILARS MARKET FORECAST (2017-2022)

14.1 Germany Biosimilars Sales Forecast (2017-2022)
14.2 France Biosimilars Sales Forecast (2017-2022)
14.3 UK Biosimilars Sales Forecast (2017-2022)
14.4 Russia Biosimilars Sales Forecast (2017-2022)
14.5 Italy Biosimilars Sales Forecast (2017-2022)
14.6 Spain Biosimilars Sales Forecast (2017-2022)
14.7 Benelux Biosimilars Sales Forecast (2017-2022)
14.8 Europe Biosimilars Sales Forecast by Type (2017-2022)
14.9 Europe Biosimilars Sales Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Biosimilars
Table Classification of Biosimilars
Figure Europe Sales Market Share of Biosimilars by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Biosimilars
Figure Europe Sales Market Share of Biosimilars by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Biosimilars Revenue and Growth Rate (2012-2022)
Figure France Biosimilars Revenue and Growth Rate (2012-2022)
Figure UK Biosimilars Revenue and Growth Rate (2012-2022)
Figure Russia Biosimilars Revenue and Growth Rate (2012-2022)
Figure Italy Biosimilars Revenue and Growth Rate (2012-2022)
Figure Spain Biosimilars Revenue and Growth Rate (2012-2022)
Figure Benelux Biosimilars Revenue and Growth Rate (2012-2022)
Figure Europe Biosimilars Sales and Growth Rate (2012-2022)
Figure Europe Biosimilars Revenue and Growth Rate (2012-2022)
Table Europe Biosimilars Sales of Key Manufacturers (2015 and 2016)
Table Europe Biosimilars Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Biosimilars Sales Share by Manufacturers
Figure 2016 Biosimilars Sales Share by Manufacturers
Table Europe Biosimilars Revenue by Manufacturers (2015 and 2016)
Table Europe Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Biosimilars Revenue Share by Manufacturers
Table 2016 Europe Biosimilars Revenue Share by Manufacturers
Table Europe Biosimilars Sales and Market Share by Type (2012-2017)
Table Europe Biosimilars Sales Share by Type (2012-2017)
Figure Sales Market Share of Biosimilars by Type (2012-2017)
Figure Europe Biosimilars Sales Growth Rate by Type (2012-2017)
Table Europe Biosimilars Revenue and Market Share by Type (2012-2017)
Table Europe Biosimilars Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biosimilars by Type (2012-2017)
Figure Europe Biosimilars Revenue Growth Rate by Type (2012-2017)
Table Europe Biosimilars Sales and Market Share by Countries (2012-2017)
Table Europe Biosimilars Sales Share by Countries (2012-2017)
Figure Sales Market Share of Biosimilars by Countries (2012-2017)
Table Europe Biosimilars Revenue and Market Share by Countries (2012-2017)
Table Europe Biosimilars Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Biosimilars by Countries (2012-2017)
Table Europe Biosimilars Sales and Market Share by Application (2012-2017)
Table Europe Biosimilars Sales Share by Application (2012-2017)
Figure Sales Market Share of Biosimilars by Application (2012-2017)
Figure Germany Biosimilars Sales and Growth Rate (2012-2017)
Figure Germany Biosimilars Revenue and Growth Rate (2012-2017)
Figure Germany Biosimilars Sales Price Trend (2012-2017)
Table Germany Biosimilars Sales by Manufacturers (2015 and 2016)
Table Germany Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Germany Biosimilars Sales by Type (2015 and 2016)
Table Germany Biosimilars Market Share by Type (2015 and 2016)
Table Germany Biosimilars Sales by Application (2015 and 2016)
Table Germany Biosimilars Market Share by Application (2015 and 2016)
Figure France Biosimilars Sales and Growth Rate (2012-2017)
Figure France Biosimilars Revenue and Growth Rate (2012-2017)
Figure France Biosimilars Sales Price Trend (2012-2017)
Table France Biosimilars Sales by Manufacturers (2015 and 2016)
Table France Biosimilars Market Share by Manufacturers (2015 and 2016)
Table France Biosimilars Sales by Type (2015 and 2016)
Table France Biosimilars Market Share by Type (2015 and 2016)
Table France Biosimilars Sales by Application (2015 and 2016)
Table France Biosimilars Market Share by Application (2015 and 2016)
Figure UK Biosimilars Sales and Growth Rate (2012-2017)
Figure UK Biosimilars Revenue and Growth Rate (2012-2017)
Figure UK Biosimilars Sales Price Trend (2012-2017)
Table UK Biosimilars Sales by Manufacturers (2015 and 2016)
Table UK Biosimilars Market Share by Manufacturers (2015 and 2016)
Table UK Biosimilars Sales by Type (2015 and 2016)
Table UK Biosimilars Market Share by Type (2015 and 2016)
Table UK Biosimilars Sales by Application (2015 and 2016)
Table UK Biosimilars Market Share by Application (2015 and 2016)
Figure Russia Biosimilars Sales and Growth Rate (2012-2017)
Figure Russia Biosimilars Revenue and Growth Rate (2012-2017)
Figure Russia Biosimilars Sales Price Trend (2012-2017)
Table Russia Biosimilars Sales by Manufacturers (2015 and 2016)
Table Russia Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Russia Biosimilars Sales by Type (2015 and 2016)
Table Russia Biosimilars Market Share by Type (2015 and 2016)
Table Russia Biosimilars Sales by Application (2015 and 2016)
Table Russia Biosimilars Market Share by Application (2015 and 2016)
Figure Italy Biosimilars Sales and Growth Rate (2012-2017)
Figure Italy Biosimilars Revenue and Growth Rate (2012-2017)
Figure Italy Biosimilars Sales Price Trend (2012-2017)
Table Italy Biosimilars Sales by Manufacturers (2015 and 2016)
Table Italy Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Italy Biosimilars Sales by Type (2015 and 2016)
Table Italy Biosimilars Market Share by Type (2015 and 2016)
Table Italy Biosimilars Sales by Application (2015 and 2016)
Table Italy Biosimilars Market Share by Application (2015 and 2016)
Figure Spain Biosimilars Sales and Growth Rate (2012-2017)
Figure Spain Biosimilars Revenue and Growth Rate (2012-2017)
Figure Spain Biosimilars Sales Price Trend (2012-2017)
Table Spain Biosimilars Sales by Manufacturers (2015 and 2016)
Table Spain Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Spain Biosimilars Sales by Type (2015 and 2016)
Table Spain Biosimilars Market Share by Type (2015 and 2016)
Table Spain Biosimilars Sales by Application (2015 and 2016)
Table Spain Biosimilars Market Share by Application (2015 and 2016)
Figure Benelux Biosimilars Sales and Growth Rate (2012-2017)
Figure Benelux Biosimilars Revenue and Growth Rate (2012-2017)
Figure Benelux Biosimilars Sales Price Trend (2012-2017)
Table Benelux Biosimilars Sales by Manufacturers (2015 and 2016)
Table Benelux Biosimilars Market Share by Manufacturers (2015 and 2016)
Table Benelux Biosimilars Sales by Type (2015 and 2016)
Table Benelux Biosimilars Market Share by Type (2015 and 2016)
Table Benelux Biosimilars Sales by Application (2015 and 2016)
Table Benelux Biosimilars Market Share by Application (2015 and 2016)
Table Biosimilars Basic Information List
Table Sandoz International Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sandoz International Biosimilars Sales Market Share (2012-2017)
Table Hospira Basic Information List
Table Hospira Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Hospira Biosimilars Sales Market Share (2012-2017)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Teva Pharmaceutical Biosimilars Sales Market Share (2012-2017)
Table Dr. Reddy’s Laboratories Basic Information List
Table Dr. Reddy’s Laboratories Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Dr. Reddy’s Laboratories Biosimilars Sales Market Share (2012-2017)
Table Biocon Basic Information List
Table Biocon Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Biocon Biosimilars Sales Market Share (2012-2017)
Table Mylan Basic Information List
Table Mylan Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Mylan Biosimilars Sales Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Biosimilars Sales Market Share (2012-2017)
Table Celltrion Basic Information List
Table Celltrion Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Celltrion Biosimilars Sales Market Share (2012-2017)
Table Roche Diagnostics Basic Information List
Table Roche Diagnostics Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Roche Diagnostics Biosimilars Sales Market Share (2012-2017)
Table Merck KGaA Basic Information List
Table Merck KGaA Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck KGaA Biosimilars Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilars
Figure Manufacturing Process Analysis of Biosimilars
Figure Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biosimilars Major Manufacturers in 2015
Table Major Buyers of Biosimilars
Table Distributors/Traders List
Figure Germany Biosimilars Sales and Growth Rate Forecast (2017-2022)
Figure Germany Biosimilars Revenue and Growth Rate Forecast (2017-2022)
Figure France Biosimilars Sales and Growth Rate Forecast (2017-2022)
Figure France Biosimilars Revenue and Growth Rate Forecast (2017-2022)
Figure UK Biosimilars Sales and Growth Rate Forecast (2017-2022)
Figure UK Biosimilars Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Biosimilars Sales and Growth Rate Forecast (2017-2022)
Figure Russia Biosimilars Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Biosimilars Sales and Growth Rate Forecast (2017-2022)
Figure Italy Biosimilars Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Biosimilars Sales and Growth Rate Forecast (2017-2022)
Figure Spain Biosimilars Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Biosimilars Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Biosimilars Revenue and Growth Rate Forecast (2017-2022)
Table Europe Biosimilars Sales Forecast by Type (2017-2022)
Table Europe Biosimilars Sales Forecast by Application (2017-2022)